Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.
about
Bile acids: emerging role in management of liver diseasesSaturated phosphatidic acids mediate saturated fatty acid-induced vascular calcification and lipotoxicity.Therapeutic targeting of bile acidsAdvances in pharmacotherapy for primary biliary cirrhosis.Hydrophobic bile acids relax rat detrusor contraction via inhibiting the opening of the Na⁺/Ca²⁺ exchanger.Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and DiabetesTreatment of Obesity: Weight Loss and Bariatric Surgery.The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5.Role of farnesoid X receptor in inflammation and resolution.Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.Management of NAFLD: a stage-based approach.Role of Bile Acid-Regulated Nuclear Receptor FXR and G Protein-Coupled Receptor TGR5 in Regulation of Cardiorenal Syndrome (Cardiovascular Disease and Chronic Kidney Disease)Bile acid metabolism in liver pathobiology.Beneficial effects of bile acid receptor agonists in pulmonary disease models.A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice.Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis.Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.Primary biliary cholangitis: new treatments for an old disease.Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formationFarnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitisBile acid signaling and bariatric surgeryBile acid receptors link nutrient sensing to metabolic regulationThe Role of Gut Microbiota in Atherosclerosis and Hypertension
P2860
Q26796318-34B08D4B-CDBB-4806-B622-AB7FC81785D8Q35827400-66FBF18B-3B49-467E-9CA1-BFB94E24ADD8Q35958534-82CC455F-BA42-4BA1-8B2C-B1F7E8951312Q36116022-EB19DA94-1DF0-47D6-BF2D-B74244AD2790Q36595434-470017DA-6C0B-46D0-8FE6-0A1EAE8F5C92Q36602170-3B23D9FC-41BA-4994-A5F5-E24A2C7BB586Q36849190-B42D21CD-E437-4E31-9779-08F1809F1924Q36956145-8C6BDA1B-B22F-4A32-94A4-DDCAC0A02665Q37255981-BAE148FD-F03F-4DC8-B843-B1A1482060B7Q38265728-7E07B81D-7632-4551-9C48-0D99C51C1414Q38628414-6DCA260D-C70B-4C00-8AD3-0AE315F2ED1BQ38747405-627CCA72-3AF0-48D4-9EC1-A6505ABB73A7Q42255441-A007F16F-2D28-4249-88DE-7AD8C2DFF1EAQ47645986-DAEAD54C-E454-45CC-9414-F6958B6AB60BQ47741857-CFBEEA42-AEE5-4E54-A57F-C0165651BD00Q47862228-B4BE41F2-12B5-4B94-9986-D8E65E1017D0Q48526360-39D07D0A-2489-4AC2-8A85-6983B57D5D91Q49374294-4B6A54B6-E2F0-453B-8352-AEF646183E35Q51016869-EC9B48EA-05C3-4DD2-9B4D-46D05ADFF354Q54390436-9F5B5244-16BF-4A94-99EE-810DA447CD63Q57109903-FB7A8F28-8107-4E73-86B0-58B7B9FAB005Q57114745-1C74DCE6-0929-425A-A5C0-C3BE858C23D0Q57124605-5CAE0915-08AF-4489-AF07-834CB1778921Q57128781-F283C3C5-735E-43D9-A829-6661E0E63AC5Q57492139-8E5BC586-41D3-4DA4-8D08-99C9BFBE7121
P2860
Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Dual activation of the bile ac ...... mice against atherosclerosis.
@ast
Dual activation of the bile ac ...... mice against atherosclerosis.
@en
Dual activation of the bile ac ...... mice against atherosclerosis.
@nl
type
label
Dual activation of the bile ac ...... mice against atherosclerosis.
@ast
Dual activation of the bile ac ...... mice against atherosclerosis.
@en
Dual activation of the bile ac ...... mice against atherosclerosis.
@nl
prefLabel
Dual activation of the bile ac ...... mice against atherosclerosis.
@ast
Dual activation of the bile ac ...... mice against atherosclerosis.
@en
Dual activation of the bile ac ...... mice against atherosclerosis.
@nl
P2093
P2860
P1433
P1476
Dual activation of the bile ac ...... mice against atherosclerosis.
@en
P2093
Audrey L Keenan
Makoto Miyazaki
Masashi Masuda
Moshe Levi
Shinobu Miyazaki-Anzai
P2860
P304
P356
10.1371/JOURNAL.PONE.0108270
P407
P577
2014-09-19T00:00:00Z